Concepedia

Marc Maliepaard

MM

Statistics

Publications

32

Citations

3.6K

H-Index

21

Active since

1990

Affiliations

The Netherlands Cancer Institute(Current)

Utrecht University

Medicines Evaluation Board

Radboud University Nijmegen

Radboud University Medical Center

Marc Maliepaard is an author at The Netherlands Cancer Institute specializing in pharmacology, medicine, and oncology.

ORCID

Publications per year

1990–2022

32

Publications

32

Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

Marc Maliepaard, George L. Scheffer, Ian F. Faneyte et al. · PubMed · 2001 · 1.1K citations

, , +14

Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.

Marc Maliepaard, M A van Gastelen, L A de Jong et al. · PubMed · 1999 · 487 citations

, , +12

Frequent expression of the multi‐drug resistance‐associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP‐21 monoclonal antibody in paraffin‐embedded material

Julio E. Diestra, George L. Scheffer, Isabel Català et al. · The Journal of Pathology · 2002 · 275 citations

, , +17

Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918.

Marc Maliepaard, Margôt A. van Gastelen, Akiko Tohgo et al. · PubMed · 2001 · 234 citations

, , +15

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.

Charles Erlichman, Scott A. Boerner, Christopher G. Hallgren et al. · PubMed · 2001 · 223 citations

, , +17

1–5 of 32